Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 653 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/25
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 08/01/23
Due: 08/01/24
Phase: N/A
Priority: Normal
Start: 05/21/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 06/30/21
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 01/01/12
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 03/01/19
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 12/01/12
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 10/01/16
End: 01/01/18
Due: 01/01/19
Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa
Phase: N/A
Priority: Normal
Start: 09/12/23
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 07/01/18
End: 07/01/19
Due: 07/01/20
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 07/01/22
Due: 07/01/23
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 01/01/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 03/31/22
Due: 03/31/23
Phase: N/A
Priority: Normal
Start: 12/01/19
End: 12/30/20
Due: 12/30/21
Phase: N/A
Priority: Normal
Start: 07/31/21
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 10/01/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 03/15/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 12/10/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 01/01/16
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 07/01/26
Due: 07/01/27